182 related articles for article (PubMed ID: 35141753)
1. Influence of daptomycin dose and fosfomycin susceptibility on outcome of vancomycin-resistant Enterococcus faecium bloodstream infections treated with daptomycin and fosfomycin combination.
Chuang YC; Tseng TC; Wang JT; Lin CY; Huang SH; Chen YC; Chang SC
J Antimicrob Chemother; 2022 Apr; 77(5):1436-1443. PubMed ID: 35141753
[TBL] [Abstract][Full Text] [Related]
2. Effect of Daptomycin Dose on the Outcome of Vancomycin-Resistant, Daptomycin-Susceptible Enterococcus faecium Bacteremia.
Chuang YC; Lin HY; Chen PY; Lin CY; Wang JT; Chen YC; Chang SC
Clin Infect Dis; 2017 Apr; 64(8):1026-1034. PubMed ID: 28329222
[TBL] [Abstract][Full Text] [Related]
3. A retrospective clinical comparison of daptomycin vs daptomycin and a beta-lactam antibiotic for treating vancomycin-resistant Enterococcus faecium bloodstream infections.
Chuang YC; Chen PY; Lin CY; Chen YC; Wang JT; Chang SC
Sci Rep; 2018 Jan; 8(1):1632. PubMed ID: 29374204
[TBL] [Abstract][Full Text] [Related]
4. Vancomycin-resistant Enterococcal Bloodstream Infections in Hematopoietic Stem Cell Transplant Recipients and Patients with Hematologic Malignancies: Impact of Daptomycin MICs of 3 to 4 mg/L.
Chong PP; van Duin D; Bangdiwala A; Ivanova A; Miller WC; Weber DJ; Gilligan PH; Shea TC
Clin Ther; 2016 Nov; 38(11):2468-2476. PubMed ID: 27771176
[TBL] [Abstract][Full Text] [Related]
5. The Combination of Daptomycin with Fosfomycin is More Effective than Daptomycin Alone in Reducing Mortality of Vancomycin-Resistant Enterococcal Bloodstream Infections: A Retrospective, Comparative Cohort Study.
Tseng TC; Chuang YC; Yang JL; Lin CY; Huang SH; Wang JT; Chen YC; Chang SC
Infect Dis Ther; 2023 Feb; 12(2):589-606. PubMed ID: 36629997
[TBL] [Abstract][Full Text] [Related]
6. The combination of daptomycin with β-lactam antibiotics is more effective than daptomycin alone for vancomycin-resistant Enterococcus faecium bloodstream infection.
Chuang YC; Wang JT; Yang JL; Lin CY; Huang SH; Chen YC; Chang SC
J Infect Public Health; 2022 Dec; 15(12):1396-1402. PubMed ID: 36371936
[TBL] [Abstract][Full Text] [Related]
7. Influence of daptomycin doses on the outcomes of VRE bloodstream infection treated with high-dose daptomycin.
Chuang YC; Lin HY; Yang JL; Lin CY; Huang SH; Wang JT; Chen YC; Chang SC
J Antimicrob Chemother; 2022 Jul; 77(8):2278-2287. PubMed ID: 35639586
[TBL] [Abstract][Full Text] [Related]
8. Daptomycin versus linezolid for the treatment of vancomycin-resistant enterococcal bacteraemia: implications of daptomycin dose.
Chuang YC; Lin HY; Chen PY; Lin CY; Wang JT; Chang SC
Clin Microbiol Infect; 2016 Oct; 22(10):890.e1-890.e7. PubMed ID: 27475738
[TBL] [Abstract][Full Text] [Related]
9. Daptomycin nonsusceptible vancomycin resistant Enterococcus bloodstream infections in patients with hematological malignancies: risk factors and outcomes.
Herc ES; Kauffman CA; Marini BL; Perissinotti AJ; Miceli MH
Leuk Lymphoma; 2017 Dec; 58(12):2852-2858. PubMed ID: 28402152
[TBL] [Abstract][Full Text] [Related]
10. Fosfomycin synergy in vitro with amoxicillin, daptomycin, and linezolid against vancomycin-resistant Enterococcus faecium from renal transplant patients with infected urinary stents.
Descourouez JL; Jorgenson MR; Wergin JE; Rose WE
Antimicrob Agents Chemother; 2013 Mar; 57(3):1518-20. PubMed ID: 23263002
[TBL] [Abstract][Full Text] [Related]
11. The importance of adjusting for enterococcus species when assessing the burden of vancomycin resistance: a cohort study including over 1000 cases of enterococcal bloodstream infections.
Kramer TS; Remschmidt C; Werner S; Behnke M; Schwab F; Werner G; Gastmeier P; Leistner R
Antimicrob Resist Infect Control; 2018; 7():133. PubMed ID: 30459945
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the Effectiveness and Safety of Linezolid and Daptomycin in Vancomycin-Resistant Enterococcal Bloodstream Infection: A National Cohort Study of Veterans Affairs Patients.
Britt NS; Potter EM; Patel N; Steed ME
Clin Infect Dis; 2015 Sep; 61(6):871-8. PubMed ID: 26063715
[TBL] [Abstract][Full Text] [Related]
13. Emergence of daptomycin non-susceptibility in colonizing vancomycin-resistant Enterococcus faecium isolates during daptomycin therapy.
Lellek H; Franke GC; Ruckert C; Wolters M; Wolschke C; Christner M; Büttner H; Alawi M; Kröger N; Rohde H
Int J Med Microbiol; 2015 Dec; 305(8):902-9. PubMed ID: 26454536
[TBL] [Abstract][Full Text] [Related]
14. Comparative Effectiveness and Safety of Standard-, Medium-, and High-Dose Daptomycin Strategies for the Treatment of Vancomycin-Resistant Enterococcal Bacteremia Among Veterans Affairs Patients.
Britt NS; Potter EM; Patel N; Steed ME
Clin Infect Dis; 2017 Mar; 64(5):605-613. PubMed ID: 28011602
[TBL] [Abstract][Full Text] [Related]
15. Daptomycin susceptibility testing and therapeutic use in enterococcal bloodstream infection (EBSI) in a setting with high rates of vancomycin-resistant Enterococcus faecium (VREfm).
Kelly J; Tysall L; Dewar S
J Antimicrob Chemother; 2022 Apr; 77(5):1432-1435. PubMed ID: 35165738
[TBL] [Abstract][Full Text] [Related]
16. Vancomycin-resistant enterococcal bacteraemia and daptomycin: are higher doses necessary?
King EA; McCoy D; Desai S; Nyirenda T; Bicking K
J Antimicrob Chemother; 2011 Sep; 66(9):2112-8. PubMed ID: 21697178
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for mortality after linezolid treatment of vancomycin-resistant Enterococcus bloodstream infection.
Huang ST; Yang JL; Lin CY; Huang SH; Wang JT; Chuang YC; Chen YC; Chang SC
Int J Infect Dis; 2023 Apr; 129():96-102. PubMed ID: 36736576
[TBL] [Abstract][Full Text] [Related]
18. Clinical Outcomes of Daptomycin for Vancomycin-resistant Enterococcus Bacteremia.
Moise PA; Sakoulas G; McKinnell JA; Lamp KC; DePestel DD; Yoon MJ; Reyes K; Zervos MJ
Clin Ther; 2015 Jul; 37(7):1443-1453.e2. PubMed ID: 25982687
[TBL] [Abstract][Full Text] [Related]
19. Influence of Minimum Inhibitory Concentration in Clinical Outcomes of Enterococcus faecium Bacteremia Treated With Daptomycin: Is it Time to Change the Breakpoint?
Shukla BS; Shelburne S; Reyes K; Kamboj M; Lewis JD; Rincon SL; Reyes J; Carvajal LP; Panesso D; Sifri CD; Zervos MJ; Pamer EG; Tran TT; Adachi J; Munita JM; Hasbun R; Arias CA
Clin Infect Dis; 2016 Jun; 62(12):1514-1520. PubMed ID: 27045126
[TBL] [Abstract][Full Text] [Related]
20. Synergistic activity of fosfomycin and chloramphenicol against vancomycin-resistant Enterococcus faecium (VREfm) isolates from bloodstream infections.
Lagatolla C; Milic J; Imperi F; Cervoni M; Bressan R; Luzzati R; Di Bella S
Diagn Microbiol Infect Dis; 2021 Feb; 99(2):115241. PubMed ID: 33130503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
